Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yao Du, Wei Song, Xiaofu Xiong, Weihong Ge & Huaijun Zhu. (2022) Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients. Xenobiotica 52:3, pages 274-283.
Read now
Read now
Xiao Chen, Dong-Dong Wang, Hong Xu & Zhi-Ping Li. (2020) Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics. Expert Review of Clinical Pharmacology 13:5, pages 553-561.
Read now
Read now
Lu Chen, Xiaoqing Lu, Guijun Tan, Liqin Zhu, Yihe Liu & Mengxue Li. (2020) Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients. Xenobiotica 50:2, pages 196-201.
Read now
Read now
Dongdong Wang, Xiao Chen, Hong Xu & Zhiping Li. (2020) Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients. Xenobiotica 50:2, pages 188-195.
Read now
Read now
Eunhee Ji, Myeong gyu Kim & Jung Mi Oh. (2018) CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation. Therapeutics and Clinical Risk Management 14, pages 2119-2126.
Read now
Read now
Thomas Vanhove, Pieter Annaert & Dirk R. J. Kuypers. (2016) Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. Drug Metabolism Reviews 48:1, pages 88-112.
Read now
Read now
Articles from other publishers (28)
Cheng-Bin Wang, Yu-jia Zhang, Ming-Ming Zhao & Li-mei Zhao. (2023) Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review. European Journal of Clinical Pharmacology 79:7, pages 897-913.
Crossref
Crossref
Zi-ran Li, Cong-huan Shen, Rui-dong Li, Bei Wang, Juan Li, Wan-jie Niu, Li-jun Zhang, Ming-kang Zhong, Zheng-xin Wang & Xiao-yan Qiu. (2023) Individual dose recommendations for drug interaction between tacrolimus and voriconazole in adult liver transplant recipients: A semiphysiologically based population pharmacokinetic modeling approach. European Journal of Pharmaceutical Sciences 184, pages 106405.
Crossref
Crossref
Ranita Kirubakaran, David W. Uster, Stefanie Hennig, Jane E. Carland, Richard O. Day, Sebastian G. Wicha & Sophie L. Stocker. (2022) Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients. British Journal of Clinical Pharmacology 89:3, pages 1162-1175.
Crossref
Crossref
Zi‐ran Li, Rui‐dong Li, Wan‐jie Niu, Xin‐yi Zheng, Zheng‐xin Wang, Ming‐kang Zhong & Xiao‐yan Qiu. (2022) Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients. The Journal of Clinical Pharmacology 63:3, pages 314-325.
Crossref
Crossref
Xiao-Jun Cai, Rui-Dong Li, Jian-Hua Li, Yi-Feng Tao, Quan-Bao Zhang, Cong-Huan Shen, Xiao-Fei Zhang, Zheng-Xin Wang & Zheng Jiao. (2022) Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models. Frontiers in Pharmacology 13.
Crossref
Crossref
Kotaro Itohara, Ikuko Yano, Shunsaku Nakagawa, Atsushi Yonezawa, Tomohiro Omura, Satoshi Imai, Takayuki Nakagawa, Atsuro Sawada, Takashi Kobayashi, Akira Tochio, Kaoru Sakai, Kojiro Taura, Osamu Ogawa & Kazuo Matsubara. (2022) Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients. Drug Metabolism and Pharmacokinetics 42, pages 100423.
Crossref
Crossref
Azza Abd El-rahman Saab, Eman Saleh El-hadidi, Maha Mohsen Hussein, Maram Saeed Abd El-baki Shararah & Heba Hassan Aly. (2021) Clinical utility of ABCB1 single nucleotide polymorphism on tacrolimus dose requirements in Egyptian liver transplant patients. Egyptian Liver Journal 11:1.
Crossref
Crossref
Yan Jing, Ying Kong, Xiongjun Hou, Hong Liu, Qun Fu, Zheng Jiao, Hongwei Peng & Xiaohua Wei. (2021) Population pharmacokinetic analysis and dosing guidelines for tacrolimus co‐administration with Wuzhi capsule in Chinese renal transplant recipients. Journal of Clinical Pharmacy and Therapeutics 46:4, pages 1117-1128.
Crossref
Crossref
Marie-Astrid Decrocq-RudlerAnna H-X. P. Chan KwongLucy Meunier, Julien FraisseJosé Ursic-Bedoya & Sonia Khier. (2021) Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice. Therapeutic Drug Monitoring 43:4, pages 490-498.
Crossref
Crossref
Saki Yoshida, Ayumi Fujimoto, Keizo Fukushima, Motozumi Ando, Kei Irie, Tatsuya Hirano, Moena Miyasaka, Yoshimitsu Shimomura, Takayuki Ishikawa, Hiroaki Ikesue, Nobuyuki Muroi, Tohru Hashida & Nobuyuki Sugioka. (2020) Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts. Journal of Clinical Pharmacy and Therapeutics 46:1, pages 190-197.
Crossref
Crossref
Ranita Kirubakaran, Sophie L. Stocker, Stefanie Hennig, Richard O. Day & Jane E. Carland. (2020) Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review. Clinical Pharmacokinetics 59:11, pages 1357-1392.
Crossref
Crossref
Jia Shao, Chenyu Wang, Peng Fu, Fan Chen, Yi Zhang & Jinxia Wei. (2019)
Impact of Donor and Recipient
CYP3A5*3
Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients
. Annals of Pharmacotherapy 54:7, pages 652-661.
Crossref
Crossref
Xiao Chen, Dongdong Wang, Hong Xu & Zhiping Li. (2019)
Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the
CYP3A5
polymorphism and coadministration with Wuzhi capsule
. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 309-317.
Crossref
Crossref
Xiaojun Cai, Ruidong Li, Changcheng Sheng, Yifeng Tao, Quanbao Zhang, Xiaofei Zhang, Juan Li, Conghuan Shen, Xiaoyan Qiu, Zhengxin Wang & Zheng Jiao. (2020) Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. European Journal of Pharmaceutical Sciences 145, pages 105237.
Crossref
Crossref
Tom M. Nanga, Thao T.P. Doan, Pierre Marquet & Flora T. Musuamba. (2019) Toward a robust tool for pharmacokinetic‐based personalization of treatment with tacrolimus in solid organ transplantation: A model‐based meta‐analysis approach. British Journal of Clinical Pharmacology 85:12, pages 2793-2823.
Crossref
Crossref
Dongdong Wang, Xiao Chen, Hong Xu & Zhiping Li. (2019) Population pharmacokinetics of tacrolimus in pediatric patients with systemic‑onset juvenile idiopathic arthritis: Initial dosage recommendations. Experimental and Therapeutic Medicine.
Crossref
Crossref
Dongdong Wang, Xiao Chen, Meng Fu, Hong Xu & Zhiping Li. (2019) Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression. International Journal of Molecular Medicine.
Crossref
Crossref
Janet K. Coller, Jeyamani Ramachandran, Libby John, Jonathan Tuke, Alan Wigg & Matthew Doogue. (2019) The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome. British Journal of Clinical Pharmacology 85:9, pages 2170-2175.
Crossref
Crossref
Mercè BrunetTeun van GelderAnders ÅsbergVincent HaufroidDennis A. HesselinkLoralie LangmanFlorian LemaitrePierre MarquetChristoph SegerMaria ShipkovaAlexander VinksPierre WallemacqEberhard WielandJean Baptiste WoillardMarkus J. BartenKlemens BuddeHelena ColomMaja-Theresa DieterlenLaure ElensKamisha L. Johnson-DavisPaweł K. KunickiIain MacPheeSatohiro MasudaBinu S. MathewOlga MillánTomoyuki MizunoDirk-Jan A. R. MoesCaroline MonchaudOfelia NocetiTomasz PawinskiNicolas PicardRon van SchaikClaudia SommererNils Tore VetheBrenda de Winter, Uwe ChristiansStein Bergan. (2019) Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Therapeutic Drug Monitoring 41:3, pages 261-307.
Crossref
Crossref
Palden Wangyel Dorji, Gyem Tshering & Kesara Na‐Bangchang. (2019) CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South‐East and East Asian populations: A systematic review. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Dongdong Wang, Jinmiao Lu, Qin Li & Zhiping Li. (2019) Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models. Experimental and Therapeutic Medicine.
Crossref
Crossref
Olivia Campagne, Donald E. Mager & Kathleen M. Tornatore. (2019) Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?. The Journal of Clinical Pharmacology 59:3, pages 309-325.
Crossref
Crossref
D.-D. Wang, J.-M. Lu, Q. Li & Z.-P. Li. (2018) Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. Journal of Clinical Pharmacy and Therapeutics 43:4, pages 476-483.
Crossref
Crossref
B. Chen, H.-Q. Shi, X.-X. Liu, W.-X. Zhang, J.-Q. Lu, B.-M. Xu & H. Chen. (2017) Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients. Journal of Clinical Pharmacy and Therapeutics 42:6, pages 679-688.
Crossref
Crossref
Yuan Liu, Tao Zhang, Changcan Li, Ling Ye, Haitao Gu, Lin Zhong, Hongcheng Sun, Yahuang Sun, Zhihai Peng & Junwei Fan. (2017)
SLC28A3
rs7853758 as a new biomarker of tacrolimus elimination and new-onset hypertension in Chinese liver transplantation patients
. Biomarkers in Medicine 11:8, pages 607-618.
Crossref
Crossref
Jianhai Wang, Keqiu Li, Xiaoning Zhang, Dahong Teng, Mingyan Ju, Yaqing Jing, Yuxia Zhao & Guang Li. (2017) The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts. Scientific Reports 7:1.
Crossref
Crossref
Emily Brooks, Susan E. Tett, Nicole M. Isbel & Christine E. Staatz. (2016) Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?. Clinical Pharmacokinetics 55:11, pages 1295-1335.
Crossref
Crossref
J. Ge, J. Wang, H. Zhao, K. Li, Y. Jing & G. Li. (2016) Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients. Transplantation Proceedings 48:6, pages 1962-1967.
Crossref
Crossref